About 200 million doses will be released in 2021 and 300 million will be distributed in the first half of 2022, an acquaintance said. Biden’s top Covid adviser, Jeff Gents, has been working on the deal last month.
All doses will go through COVAX, the international vaccine initiative, and will go to 92 low- and low-income countries in addition to the African Union.
In addition to the purchase of Pfizer, Biden is also expected to participate in a joint announcement with the G7 on a comprehensive plan to end the pandemic, White House National Security Adviser Jake Sullivan told reporters aboard Air Force One on Wednesday. is. This will include a section on vaccines.
Sullivan argued that the US has a major role in global COVID-19 vaccine distribution, which Americans do in times of need and would be beneficial to prevent future spread of the disease in the US.
“He wants to rally the rest of the world to democracies – democracies are countries that can provide the best solutions for people everywhere. That goes for Covid-19, that goes for climate change, that goes for economic goes for reform and it goes for the basic human rights and human dignity of all people,” Sullivan said.
Biden had previously committed to sharing 80 million doses of the vaccine with other countries. That part also included Pfizer supplements.
The White House said at least 75% of the donated vaccines would be shared with a global immunization program called COVID-19 Vaccine Global Access, or COVAX, and 25% would be shared directly with countries in need.
Biden said last month the US would share an additional 20 million doses of COVID-19 vaccines by the end of June, on top of the 60 million doses of the AstraZeneca vaccine the president had already committed to sharing by July 4. An additional 20 million doses will include vaccines from Moderna, Pfizer and Johnson & Johnson as well as AstraZeneca, which have to be approved by federal regulators before being shipped overseas.
This story has been updated with additional details on Wednesday.
CNN’s Kate Sullivan contributed to this report.